The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods

Harold I Feldman1, Lawrence J Appel, Glenn M Chertow

  • 1Center for Clinical Epidemiology, Philadelphia, 19104, USA. hfeldman@cceb.med.upenn.edu

Insights

The Chronic Renal Insufficiency Cohort (CRIC) study investigates chronic renal insufficiency (CRI) and cardiovascular disease (CVD) risk factors. Findings aim to identify high-risk patients for targeted therapies and preventive strategies.

Area of Science:

  • Nephrology
  • Cardiology
  • Epidemiology

Background:

  • Limited understanding of chronic renal insufficiency (CRI) epidemiology and its link to cardiovascular disease (CVD).
  • Need for research on risk factors for CRI progression and CVD in affected patients.

Purpose of the Study:

  • To examine risk factors for CRI progression and CVD in CRI patients.
  • To develop models for identifying high-risk subgroups.
  • To inform future treatment trials and preventive therapy application.

Main Methods:

  • Enrollment of ~3000 diverse adults (21-74 yrs) with varying renal disease severity, including those with diabetes.
  • Exclusion of patients with polycystic kidney disease or on immunosuppression for glomerulonephritis.
  • Annual clinical evaluations, semi-annual telephone follow-ups, and serial measurements including (125)I-iothalamate clearances and CVD assessments (ECG, echocardiogram, CT).

Main Results:

  • Data collection on quality of life, diet, physical activity, health behaviors, depression, cognitive function, and healthcare utilization.
  • Serial (125)I-iothalamate clearances to assess renal function.
  • Comprehensive cardiovascular disease evaluations including ECG, echocardiogram, and CT scans.

Conclusions:

  • Planned analyses will identify potential risk factors for progressive CRI and CVD.
  • Study insights will generate hypotheses for targeted interventional trials.
  • Aims to reduce the overall burden of CRI and CVD.

Related Concept Videos

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance01:25

Drug Dosing in Renal Diseases: Measurement of Serum Creatinine Concentration and Clearance

In healthy individuals, serum creatinine levels remain stable due to a balance between its constant production—primarily from muscle metabolism—and renal excretion. Creatinine is freely filtered by the glomeruli, making it a valuable marker for estimating renal function. When the glomerular filtration rate (GFR) decreases, the kidneys can only eliminate less creatinine, causing serum levels to rise.Serum creatinine concentration is widely used to estimate creatinine clearance (Clcr), a...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...